HIS UNKNOWN CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3beta-25-DIOL, DISULPHATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATAL DISEASES AND Atherosclerosis
5-cholesten-3, 25-diol, disulfate (25HCDS) has been found to be an authentic PPAR ³ agonist and LXR antagonist, and is used for the therapy of lipid disorders and inflammatory diseases, including without limitation fatty liver, inflammatory bowel, and atherosclerotic diseases.